Phase 2 results at 48 weeks (Jastreboff et al., NEJM 2023): Phase 3 TRIUMPH-4 at 68 weeks (Lilly Press Release, Dec 2025): The 12 mg dose produced 28.7% body weight loss, an average of 71.2 lbs from a 248.5 lb baseline
But its a powerful example of how the body can heal when you combine modern recovery technology with the right mindset
For someone who wants a minimally invasive addition to their existing diet and exercise program, the risk-to-reward ratio is very low because the risks are essentially zero
Strategies that modulate FAO or glutamine metabolism may present promising interventions for diseases steered by T cell responses (107, 108)
Skin, hair and scalp routines need to be used properly, not randomly
Testosterone and metabolic peptides Men with low testosterone may experience attenuated weight loss responses